12 10 E 16:30 17:30 : ( ) " " ( ) 12 10 15:50 16:20 A 1 ( ) ( ) B ( ) ( ) D ( ) (
12 11 B 10:00 12:00 " " ( ) ( ) 2
(10 ) A 1 ( ) 8:30 12:40 8:30 9:20 1 ( ) 1A-01 Cannabidiol-2',6'-dimethyl ether ( 1, 2, 3 ) 1, 1, 1, 2, 3, 1 1A-02 ( 1 2, 3, 4 ) 1,4 2 3 4 1 1A-03 ( ),,,,,, 1A-04 Ca ( 1, 2, 3 ) 1, 2, 2,3, 1, 3, 2,3 9:20 10:15 2 ( ) 1A-05 β- ( ),,,, 1A-06 / ( ),,,, 1A-07 ( 1, 2, 3 ) 1, 1,2, 1,2, 1, 1,3, 1,2 1A-08 ( 1, 2, 3 ) 1, 1, 1, 1,2, 1, 1,2, 1,2, 1,3, 1,2 10:15 11:10 3 1A-09 ( 1, 2 ) 1, 1, 2, 2, 1 1A-10 CYP3A4 ( ),, 1A-11 ( 1, 2, 3, 4 ) 1, 2, 3, 4, 2, 2, 2 1A-12 ( 1, 2 ) 1, 2, 2, 2, 2, 2, 2 11:10 12:00 4 ( ) 1A-13 ATF4 ( ),,, 3
, 1A-14 Ampicillin/sulbactam ( 1, 2, 3, 4, 5 ) 1, 2,,,, 4, 4, 1, 2, 5, 1,2 1A-15 Alport p53 (, COE ) 1,2, 1,2, 1,2, 1,2, 1,2, 1,2, 1,2 1A-16 EGFR-tyrosine kinase ( 1, 2, 3, ) 1, 1,2, 3,, 1,2 12:00 12:40 5 ( ) 1A-17 PK-PD ( 1, 2, 3, 4, 5 ) 1, 2, 1, 2, 2, 2, 3, 3, 4, 4, 5, 1, 2 1A-18 /α- NF-κB decoy ( ),,, 1A-19 ( ),,,,,, B ( ) 8:30 12:25 8:30 9:20 1 ( ) 1B-01 UDP-glucuronosyltransferase 1A9 2B7 cytochrome P450 3A4 ( 1, 2, 3, 4 ) 1, 1, 1, 2, 3, Peter I. Mackenzie 4, 1 1B-02 IL-4/IL-13 M2, APP23 ( ),,, 1B-03 Myosin 1E ( ),,,, 1B-04 β GRK5/ β 2,,,, 9:20 10:15 2 ( ) 1B-05 PGG ( 1, 2, 3 ) 1, 2, 1, 3, 2, 1 1B-06 MIP-T3 ( ),, 1B-07 physical medicine( 1, 4
COE 2 ) 1,2, 1,2, 1,2, 1,2, 1,2, 1,2, 1,2, 1,2, 1,2 1B-08 liver PPARγ-dependent gene 1 ( 1, 2 ) 1, 1, 2, 1 10:15 11:20 3 ( ) 1B-09 SIRT1 ( 1, 2, 3 ) 1, 1, 2, 1, 3,,,,, 1B-10 ( ),, 1B-11 ( ),, 1B-12 HIV-1 Nef ( 1, 2 ) 1, 1, 1, 1, 2, 1 1B-13 HIV HIV ( 1, 2, 3 ) 1, 1, 3, 1,3, 3, 1, 1, 1,2 11:20 12:25 4 ( ) 1B-14 HIV ( 1, 2 ) 1, 1, 1, 1,2, 1 1B-15 HIV ( 1, 2 ) 1, 1, 1, 1, 1,2, 1 1B-16 N ( 1, COE 2, 3, 4, 5 ) 1,2, 1,2,3, 1,2, 1,2, 4, 5, 1,2, 1,2, 1,2 1B-17 UDP- ( ),,, 1B-18 ( ), C ( ) 8:30 12:30 8:30 9:20 1 ( ) 1C-01 ( ),,, 1C-02 ( ),,, 1C-03 5 ( 1, 2, 3 ) 1, 1, 1, 2, 2, 3, 1 5
1C-04 DNA2 ( ), 9:25 10:20 2 ( ) 1C-05 8- ( ), 1C-06 p53-mdm2 ( ),, 1C-07 Ubc13-Uev1A Lissodendryx fibrosa ( ),,, 1C-08 Lewis Ar-DIOPO ( 1, 2 ) 1, 1, 1, 2, 1, 1 10:25 11:15 3 ( ) 1C-09 ( 1, 2 ) 1, 2, 1, 1 1C-10 ( ) Clausenamide ( ),,,, 1C-11 ( ),,,, 1C-12 ( 1, 2 ) 1, 2,, 1 11:20 12:30 4 ( ) 1C-13 P-, ( ),,, 1C-14 (Spondylus sp.) (PBDE-OH) O- ( 1, 2 ) 1, 1, 2, 1 1C-15 ( 1, 2, 3, 4 ) 1, 2, 3, 3, 1, 1, 4, 3, 1, 3 1C-16 E-Z ( 1, 2 ) 1, 1, 2, 1, 1 1C-17 C2 ( 1, 2 ) 1, 1, 2, 1, 1 D ( ) 8:30 12:10 8:30 9:10 1 ( ) 1D-01 ( 1, 2, 3, 4, 5 ) 1,, 1, 1, 3, 4, 5, 5, 1 1D-02 dihydropyrazine -3( ),,, 6
1D-03 dihydropyrazine -4( ),,, 1D-04 9:10 10:00 2 ( ) 1D-05 ( ),,,, 1D-06 ( ),,,,, 1D-07 ( 1, 2, 3 ) 1,, 3, 2, 2, 2 1D-08 ( ),, 10:00 10:55 ( ) 1D-09 7-N,N- FRET ( ),,,,, 1D-10 HPLC ( ),,,,,,, 1D-11 ( 1, 2 ) 1, 2, 1, 2 1D-12 [15] ( ),,,,, 10:55 11:45 4 ( ) 1D-13 ( ),,,,,, 1D-14 (F4H11OH) DPPC ( ),,,,, 1D-15 ( ),, 1D-16 ( ),, 11:45 12:1= 5 ( ) 1D-17 ESR MRI ( ),, 1D-18 In vivo ESR ( ),, 7
(10 ) A-1 ( ) 13:30 15:40 13:30 14:50 6 ( ) 1A-20 ( ),,,,,,, 1A-21 ( ),,,,,,, 1A-22 ( ),,,, 1A-23 Factor X/Factor Y ( ),,,, 1A-24 3(AQP3) ( ),,, 1A-25 ( ),,,, 14:50 15:40 7 ( ) 1A-26 ( 1, GSM 2 ) 1, 1, 1, 2, 1, 1, 1, 1, 1 1A-27 MRSA PK-PD ( ),,,, 1A-28 ( 1, 2 ) 1, 1, 2, 2, 1,2 1A-29 ( ),,, B ( ) 13:30 14:55 13:30 14:10 5 ( ) 1B-19 FM3A ( ),,, 1B-20 liver PPARγ-dependent gene 3 ( 1, 2 ) 1, 1, 1, 2, 1 1B-21 liver PPARγ-dependent gene 2 ( 1, 2 ) 1, 1, 1, 2, 1 1B-22 PI3K ( 1, 2, 3 ) 1, 2, 3, 1, 1, 1, 1 8
14:15 14:55 6 ( ) 1B-23 ( ),,,,,,, 1B-24 Inhibition of HIV-1 Preotease Expression in T cells Using CD4 aptamer sirna Chimeras( 1, COE 2 ) 1, 1, 1, 1,2 1B-25 NC (, ) 1,,,,,,,,,,, 1B-26 ( ),,,,,,,, C ( ) 13:30 15:40 13:30 14:35 5 ( ) 1C-18 A ( ),,, 1C-19 cmc-a ( 1, 2 ) 1, 1, 1, Jacques Eustache 2, 1 1C-20 ( ),,, 1C-21 Conia- ( ),,, 1C-22 ( ),,, 14:35 15:40 6 ( ) 1C-23 -exo- ( ),,, 1C-24 4 ( 1, 2, 3 ) 1, 1, 1, 2, 2, 3, 1 1C-25 β- ( 1, 2 ) 1, 2, 1, 2, 1 1C-26 -, Oppositinine A B ( ),, 1C-27 Jolkinolide ( 1, 2 ) 1, Guo-Wei Qin, 1, 1 D ( ) 13:30 15:40 13:30 14:35 6 ( ) 1D-19 ( ) Xanthatin 1 GADD45γ ( 1, 2, 3 ) 1, 1, 2, 1, 3, 1 9
1D-20 ( ) Xanthatin 2 IIα ( 1, 2, 3 ) 1, 1, 2, 1, 3, 1 1D-21 2,2',4,5'-tetrabromobiphenyl(BB49) in vitro ( ),,,,,,, 1D-22 TCDD prolactin ( 1, 2, 3 ) 1, 1, 1, 1, 1, 2, 3, 2, 1 1D-23 2,3,7,8-Tetrachlorodibenzo-p-dioxin ( 1, 2 ) 1, 1,2, 1, 1, 1 14:35 15:40 7 ( ) 1D-24 dihydropyrazine -1( ),,, 1D-25 dihydropyrazine -2( ),,,, 1D-26 MDMA Detection window ( ),,,, 1D-27 HPLC- ( ),,,,,, 1D-28 ( 1, 2, 3 ) 1, 1, 1, 2, 3, 1, 1, 2, 2, 1 2 (11 ) A 1 ( ) 8:30 12:40 8:30 9:35 8 ( ) 2A-01 (H12(ADP) ) ( 1, 2, 3, 4, 5 ) 1, 1, 1,2, 3, 3, 3, 3, 4, 1,2, 5, 1, 2 2A-02 - ( 1, 2, ) 1, 1, 1,2, 1, 1,2, 1, 1,3, 1,2 2A-03 ( 1, 2, 3 ) 1, 1, 1,2, 1,2, 1,3, 1,2 2A-04 ESI-TOF/MS ( 1, 2, 3, 4, 5 ) 1, 1, 1,2, 1,2, 3, 4, 1,5, 1,2 10
2A-05 ( ),, 9:35 10:40 9 ( ) 2A-06 ( 1, 2, 3, 4, 5 ) 1, 2, 3, 4, 4, 4, 5, 5, 2, 2, 2 2A-07 ( 1 ) 1, 1, 1, 1 2A-08 C / E (CME) ( 1, 2, 3 ) 1, 1, 1, 1, 1, 1, 1 2A-09 Smad4 ( ),,,,, 2A-10 VDR ( ),,,,,, 10:40 11:30 10 ( ) 2A-11 ( ),,,, 2A-12 Pemetrexed (Alimta) ( ),,, 2A-13 physical medicine ( 1, COE 2 ) 1,2, 1,2, 1,2, 1,2, 1,2, 1,2, 1,2 2A-14 alport physical medicine ( 1, COE 2 ) 1,2, 1,2, 1,2, 1,2, 1,2, 1,2, 1,2, 1,2, 1,2 11:30 12:40 11 ( ) 2A-15 2 ( ),,, 2A-16 2- -β- ( 1 DDS 2 ) 1, 1, 1, 2, 1 2A-17 ( 1 2 ) 1 1 1 1 1 1 2 1 2A-18 ( ),,,,, 11
2A-19 BAY 11-7082, ( 1, 2, 3, 4, 5 ) 1, 1,, 3, 2,4, 5, 1 A 2 ( ) 8:30 10:15 8:30 9:20 12 ( ) 2A-20 PK/PD ( 1, 2 ) 1, 2, 1, 2, 1 2A-21 ABCG2 mirna ( ),,,, 2A-22 PCFT 5' SNPs ( ),, 2A-23 DPYD mirna ( ),, 9:20 10:15 13 ( ) 2A-24 ( 1, 2 ) 1,, 1, 1,,, 1 2A-25 AMPK-SREBP ( 1, 2 ) 1, 2, 2, 2, 2, 2, 1,2, 2 2A-26 ( ),,,,,,, 2A-27 ( ),,,,,,,,, B ( ) 8:30 9:40 8:30 9:35 7 ( ) 2B-01 ERK-MAP ( ),,, 2B-02 ( 1, 2 ) 1, 1, 1, 1, 1, 1, 2, 1 2B-03 [2]Rotaxane ( ),,, 2B-04 poly ADP ribose polymerase olaparib T ( 1, 2 ) 1, 1, 2, 1 2B-05 (, 2, 3 ),,,,, 2, 3 12
, C ( ) 8:30 12:15 8:30 9:35 7 ( ) 2C-01 2' C4' DNA ( ),,,,, 2C-02 1,4- ( ),, 2C-03 2' C4' ( ),,, 2C-04 ( ), John Brazier,, 2C-05 3 DNA 1'-1'- ( ),,, 9:35 10:40 8 ( ) 2C-06 Garlic Sulfoxide (10)( ),, 2C-07 Garlic Sulfoxide (11)( ),, 2C-08 (146) Solanum jasminoides ( ),, 2C-09 ( 1, 2, 3 ) 1, 1, 1, 2, 2, 3, 3, 3, 3, 1, 1 2C-10 ( 1, 2, 3 ) 1, 1, 1, 2, 2, 3, 3, 1 10:40 11:20 9 ( ) 2C-11 Pachypell Manzamine ( 1, 2 ) 1 1 1 2 2 2C-12 [2.2.2] notoamide ( ),,, 2C-13 ( 1, 2 ) 1,, 1, 1 11:20 12:10 10 ( ) 2C-14 ( 1, 2 ) 1, 2C-15 Morita-Baylis-Hillman ( 1, 2 ) 1, 2C-16 ( 1, Department of Chemistry, University of Pittsburgh 2 ) 1,2, 2 13
2C-17 6 ( 1, 2 ),,,, 14